Google's Gradient Ventures unit was part of a series A round that will enable the biological research startup to boost its headcount.
Canada-based biological research index developer BenchSci received $8m on Wednesday in a series A round that included Gradient Ventures, internet technology provider Google’s artificial intelligence investment vehicle.
Venture capital firm iNovia led the round, which also featured Golden Venture Partners, Afore Capital, Real Ventures and Radical Ventures.
BenchSci’s data analytics software applies machine learning to index information from biomedical research papers, allowing researchers to more easily find reliable antibodies. It claims the technology can find relevant antibodies 24 times faster…
